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In the United States and in many other developed countries, obesity is becoming an increasingly 
widespread problem due to several factors including poor nutrition and sedentary lifestyles. 
Previous studies have shown obese people to have less circulating vitamin D than lean people 
and this study aimed to determine whether obese mothers pass less vitamin D through their 
placenta to their offspring than lean mothers do and whether vitamin D deficiency resulting in 
fewer vitamin D receptors in the placenta can be reversed by treatment of placental cells with the 
active and inactive forms of vitamin D. The data collected from this study show that placentas 
from obese mothers have less vitamin D receptors than placentas from lean mothers and that 
placental cells treated with the active form of vitamin D show increased expression of vitamin D 
receptors. Preliminary tests of mitochondrial respiration have found that placental cells from an 
obese mother respond more dramatically in terms of oxygen consumption rate to treatment with 
both the active and inactive forms of vitamin D than placental cells from a lean mother do. 
Vitamin D plays an important role in the placenta, and future studies should be conducted to 





Obesity is becoming an increasingly prevalent health problem in many developed countries. 
In the United States, it is estimated that over one-third of the adult population is obese, measured 
by having a Body Mass Index (BMI) greater than 30 (Hales et al. 2018). Obesity has been shown 
to be a risk factor for a number of health problems including hypertension and cardiovascular 
disease. These health problems can also be passed to future generations, as previous studies have 
shown that offspring of obese mothers are predisposed to obesity and to health problems 
associated with obesity. It is estimated that over 40% of women who enter pregnancy in the 
United States are either overweight or obese (Chu et al. 2009), showing just how widespread this 
problem is becoming.  
Previous studies have shown obese people to have lower levels of circulating vitamin D than 
lean people, though the cause for this has not yet been extensively studied (Santos et al. 2015). 
Vitamin D is a lipid soluble vitamin that has important properties including aiding in calcium 
absorption, being antimicrobial, and helping to reduce inflammation. Vitamin D does not occur 
naturally in many foods and is best obtained through direct sunlight exposure resulting in its 
synthesis or through vitamin D supplements resulting in absorption. Once vitamin D enters the 
bloodstream, it is converted to its inactive form [25(OH)D] in the liver and subsequently to its 
active form [1,25(OH)2D] in the kidney (Danik and Manson 2012). Previous studies have found 
evidence to support that vitamin D has an important role in regulating immune responses during 
gestation (Liu et al. 2011) and another study found that offspring of mothers who had low 
circulating vitamin D concentrations during late pregnancy had reduced bone mass at 9 years of 
age (Javaid et al. 2006).  
This study aimed at testing the hypothesis that obese mothers pass less vitamin D through 
their placenta to their offspring than lean mothers, based on the knowledge that obese people 
tend to have less circulating vitamin D than lean people. This study also aimed to observe if 
treatment of cytotrophoblasts (the main cell type in the placenta) with vitamin D could increase 
vitamin D receptor (VDR) levels in placental cells and partially reverse the effects of deficiency. 
Human placentas were collected for this study following Caesarean sections and Western blots 
were run to measure VDR levels in placentas of lean and obese mothers who had male or female 
offspring. Cytotrophoblasts were also isolated from collected placentas and were treated with 
active and inactive forms of vitamin D for 24 and 48 hours so that vitamin D receptor levels and 
mitochondrial respiration could be measured with treated cells to determine if deficiency could 
possibly be partially reversed with vitamin D treatment. Vitamin D levels were also measured in 
corresponding maternal serum and cord blood samples to observe whether maternal serum and 
cord blood vitamin D levels are positively correlated and whether maternal serum vitamin D 
levels were correlated with maternal BMI.  
 
 
Materials and Methods 
 
Sample Collection – Placentas were collected from Caesarean-section births at Oregon Health 
and Sciences University in Portland, Oregon and were classified as either coming from a lean 
(18.0-24.9), overweight (25.0-29.9), or obese (>30.0 BMI) mother.  
 
Tissue Processing and Sampling – Tissue was collected from five different locations on each 
placenta, the samples were combined and homogenized in lysis buffer using a mini-bead beater.  
 
Maternal serum and cord blood vitamin D content – An ELISA Vitamin D plate (abcam) was 
used to determine the vitamin D active form concentrations in maternal and cord blood pairs.  
 
Western Blotting – Proteins were separated on PAGE gels and were then transferred onto 
nitrocellulose membranes. Membranes were blocked in 5% nonfat milk powder in TBST 
solution and blots were probed in VDR primary antibody in 1% nonfat milk powder in TBST 
solution overnight in a 4o C cold room. Blots were then probed for one hour in secondary 
antibody in 1% nonfat milk powder in TBST at room temperature. Membranes were visualized 
using chemiluminescence and band intensity was measured using a G:Box.  
 
Isolation of cytotrophoblasts cells – Cytotrophoblasts were isolated from placental samples 
collected after C-section births by another member in the lab. Cytotrophoblasts were then treated 
with active and inactive forms of vitamin D for 24 and 48 hours and VDR levels and 
mitochondrial respiration of cells was then measured.  
 
Measure of mitochondrial respiration – Mitochondrial respiration of cytotrophoblasts treated 
with active and inactive forms of vitamin D was determined by using Seahorse equipment after 
cells had been plated for 72 hours.  
 
Statistical analysis – Data was analyzed using Microsoft Excel and GraphPad to determine the p-
value of data sets.  
 
Results 
Table 1 – Clinical data of study participants  
Pre-pregnancy or First 
Trimester BMI Group NW OB 







Female      
n=6 



































Figure 1 – ELISA plate results showing the relationship between maternal BMI and maternal 
serum vitamin D concentration 
 
 
Figure 2 – ELISA plate results showing the relationship between maternal and cord blood serum 







































































































Figure 3 – Vitamin D receptors in placentas of lean and obese offspring for females (A) and 
males (B)  
  
Figure 4 – Effect of active and inactive forms of vitamin D treatment on vitamin D receptor 
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This investigation looked at vitamin D and vitamin D receptor levels in placental and 
serum samples to determine the effects of maternal obesity on vitamin D concentrations in the 
placenta and to evaluate the importance of vitamin D in cytotrophoblasts mitochondrial 
respiration. Previous studies have shown that obese people have less circulating vitamin D than 
lean people. Vitamin D deficiency has been linked to health problems including preeclampsia, 
Cesarean section delivery, and gestational diabetes in pregnant women and to problems 
including weak bones, low birth weight, type 1 diabetes, and schizophrenia in infants and 
children (Shin et al. 2010).  
Vitamin D Concentrations in Maternal Serum and Cord Blood Samples  
A positive correlation was seen between corresponding maternal serum and cord blood 
vitamin D concentrations. Increasing the sample size will help determine the strength of this 
trend. This positive correlation indicates that the mother likely is passing vitamin D through her 
placenta to her offspring and that maternal serum vitamin D levels contribute to the vitamin D 
levels in the cord blood of the offspring, which is likely similar to the serum vitamin D 
concentration of the offspring.   
Vitamin D Receptor Expression in the Placenta  
Vitamin D and vitamin D receptors are present in the placenta. Vitamin D is thought to 
play a role in reducing inflammation and infection in the placenta (Liu et al. 2009). Placentas 
from obese mothers who had female offspring were shown to have statistically significantly 
lower levels of vitamin D receptors than placentas from lean mothers who had female offspring. 
A similar trend was seen with obese and lean mothers of male offspring, though the data was not 
shown to be significant. Less vitamin D receptors on the placenta means that less active vitamin 
D can bind to and be utilized by the organ. Based on previous research, less vitamin D binding 
potentially will lead to an increased risk for infection and inflammation in the placenta.  
Treatment of Cytotrophoblasts with Vitamin D 
Cytotrophoblasts treated with the active form of vitamin D (calcitriol) for 24 and 48 
hours were shown to have a positive dose dependent response with the concentration of vitamin 
D treatment correlating to the amount of vitamin D receptors in the cells after both time points. A 
definitive trend was not seen in cells treated with the inactive form of vitamin D (calcifediol). 
These results indicate that, to some extent, treatment with the active form of vitamin D can 
increase vitamin D receptor levels and can decrease deficiency in cytotrophoblasts cells. 
However, the concentration of vitamin D that deficient placental cells should be treated with the 
restore proper placental function is not yet known.  
Mitochondrial Respiration in Cytotrophoblasts Treated with Vitamin D  
  We are still working to increase the sample size for this experiment, though preliminary 
findings show that vitamin D treatment of cytotrophoblasts affects mitochondrial respiration 
much more in cytotrophoblasts from an obese mother than in cytotrophoblasts from a lean 
mother. This indicates that placental cells from an obese mother are likely in a greater state of 
stress than placental cells from a lean mother, because placental cells from an obese mother had 
a much more dramatic change in respiration when treated with both forms of vitamin D than was 
seen with placental cells from a lean mother. Once the entire data set has been normalized, more 
analysis can be done and conclusions can be drawn as to the significance of the results.  
 
Vitamin D is important for its role in calcium absorption and for its anti-inflammatory 
and antimicrobial properties. Vitamin D is important in the placenta and an adequate amount of 
circulating vitamin D is important for a healthy pregnancy and for healthy fetal development. 
Vitamin D differences between the placentas of lean and obese mothers have been shown in this 
study and further studies should be conducted to determine the extent of the role vitamin D plays 
in the placenta and the dosage of vitamin D that pregnant women should take to reverse the 
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